We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights JPMorgan Chase, Chevron, Salesforce, CVS Health and FedEx
Read MoreHide Full Article
For Immediate Release
Chicago, IL – January 12, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: JPMorgan Chase & Co. (JPM - Free Report) , Chevron Corp. (CVX - Free Report) , Salesforce, Inc. (CRM - Free Report) , CVS Health Corp. (CVS - Free Report) and FedEx Corp. (FDX - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Research Reports for JPMorgan Chase, Chevron and Salesforce.com
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co., Chevron Corp. and Salesforce, Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of JPMorgan Chase have outperformed the Zacks Banks - Major Regional industry over the past six months (+22.7% vs. +10.5%). The company’s opening of new branches, strategic acquisitions/investments and global expansion and digitization initiatives will keep driving financials. Higher rates and a steady rise in loan demand will keep bolstering net interest income (NII) growth.
According to Zacks analyst estimates for NII (managed), figures are for a CAGR of 13% over the next three years. However, the volatile nature of the capital markets business and higher mortgage rates are likely to make fee income growth challenging.
Our estimates for managed NII reflect a decline of 11.6% for 2022. Steadily rising operating expenses remain a major headwind, and we expect the same to rise 7% in 2022. Given the possibility of an economic slowdown, the company is expected to keep increasing provisions, with 2022 witnessing a substantial jump.
Shares of Chevron have outperformed the Zacks Oil and Gas - Integrated - International industry over the past year (+38.3% vs. +31.7%). The company is considered one of the best-placed global integrated oil firms to achieve sustainable production ramp-up.
America’s No. 2 energy firm’s existing project pipeline is among the best in the industry, thanks to its premier position in the lucrative Permian Basin. As a reflection of these positives, we expect CVX’s EPS to jump 132% in 2022.
However, Chevron was not immune to the commodity price crash of 2020, forcing the company to cut spending substantially. Its high oil price sensitivity is a concern too. Moreover, the supermajor’s 10-year reserve replacement ratio of 100% is indicative of its inability to replace the amount of oil and gas produced.
Salesforce shares have underperformed the Zacks Computer - Software industry over the past year (-38.0% vs. -27.0%). The company is facing stiff competition, which is a concern. Unfavorable currency fluctuations, along with increasing investments in international expansions and data centers, are overhangs on near-term profitability.
Nevertheless, Salesforce is benefiting from a robust demand environment, as customers are undergoing a major digital transformation. The rapid adoption of its cloud-based solutions is driving demand for its products. Its sustained focus on introducing more aligned products as per customer needs is driving its top-line.
Continued deal wins in the international market is another growth driver. The acquisition of Slack would position the company to be a leader in enterprise team collaboration solutions and better compete with Microsoft’s Teams product. We expect CRM revenues to grow at a CAGR of 12.5% through fiscal 2023-2025.
Other noteworthy reports we are featuring today include CVS Health Corp. and FedEx Corp.
Why Haven’t You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights JPMorgan Chase, Chevron, Salesforce, CVS Health and FedEx
For Immediate Release
Chicago, IL – January 12, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: JPMorgan Chase & Co. (JPM - Free Report) , Chevron Corp. (CVX - Free Report) , Salesforce, Inc. (CRM - Free Report) , CVS Health Corp. (CVS - Free Report) and FedEx Corp. (FDX - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Research Reports for JPMorgan Chase, Chevron and Salesforce.com
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co., Chevron Corp. and Salesforce, Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of JPMorgan Chase have outperformed the Zacks Banks - Major Regional industry over the past six months (+22.7% vs. +10.5%). The company’s opening of new branches, strategic acquisitions/investments and global expansion and digitization initiatives will keep driving financials. Higher rates and a steady rise in loan demand will keep bolstering net interest income (NII) growth.
According to Zacks analyst estimates for NII (managed), figures are for a CAGR of 13% over the next three years. However, the volatile nature of the capital markets business and higher mortgage rates are likely to make fee income growth challenging.
Our estimates for managed NII reflect a decline of 11.6% for 2022. Steadily rising operating expenses remain a major headwind, and we expect the same to rise 7% in 2022. Given the possibility of an economic slowdown, the company is expected to keep increasing provisions, with 2022 witnessing a substantial jump.
(You can read the full research report on JPMorgan Chase here >>>)
Shares of Chevron have outperformed the Zacks Oil and Gas - Integrated - International industry over the past year (+38.3% vs. +31.7%). The company is considered one of the best-placed global integrated oil firms to achieve sustainable production ramp-up.
America’s No. 2 energy firm’s existing project pipeline is among the best in the industry, thanks to its premier position in the lucrative Permian Basin. As a reflection of these positives, we expect CVX’s EPS to jump 132% in 2022.
However, Chevron was not immune to the commodity price crash of 2020, forcing the company to cut spending substantially. Its high oil price sensitivity is a concern too. Moreover, the supermajor’s 10-year reserve replacement ratio of 100% is indicative of its inability to replace the amount of oil and gas produced.
(You can read the full research report on Chevron here >>>)
Salesforce shares have underperformed the Zacks Computer - Software industry over the past year (-38.0% vs. -27.0%). The company is facing stiff competition, which is a concern. Unfavorable currency fluctuations, along with increasing investments in international expansions and data centers, are overhangs on near-term profitability.
Nevertheless, Salesforce is benefiting from a robust demand environment, as customers are undergoing a major digital transformation. The rapid adoption of its cloud-based solutions is driving demand for its products. Its sustained focus on introducing more aligned products as per customer needs is driving its top-line.
Continued deal wins in the international market is another growth driver. The acquisition of Slack would position the company to be a leader in enterprise team collaboration solutions and better compete with Microsoft’s Teams product. We expect CRM revenues to grow at a CAGR of 12.5% through fiscal 2023-2025.
(You can read the full research report on Salesforce here >>>)
Other noteworthy reports we are featuring today include CVS Health Corp. and FedEx Corp.
Why Haven’t You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.